Search

Author/Creator Fox, Edward J

6. Ocrelizumab reduces progression of upper extremity impairment in patients with primary progressive multiple sclerosis: Findings from the phase III randomized ORATORIO trial. (December 2018)

Authors:
Fox, Edward J; Markowitz, Clyde; Applebee, Angela; Montalban, Xavier; Wolinsky, Jerry S; Belachew, Shibeshih; Fiore, Damian; Pei, Jinglan; Musch, Bruno; Giovannoni, Gavin
Journal:
Multiple sclerosis
Issue:
Volume 24:Number 14(2018)
Page Start:
1862
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study. (May 2022)

Authors:
Bar-Or, Amit; Wiendl, Heinz; Montalban, Xavier; Alvarez, Enrique; Davydovskaya, Maria; Delgado, Silvia R; Evdoshenko, Evgeniy P; Giedraitiene, Natasa; Gross-Paju, Katrin; Haldre, Sulev; Herrman, Craig E; Izquierdo, Guillermo; Karelis, Guntis; Leutmezer, Fritz; Mares, Miroslav; Meca-Lallana, Jose ...
Journal:
Multiple sclerosis
Issue:
Volume 28:Number 6(2022)
Page Start:
910
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗